Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

King Faisal Specialist Hospital & Research Center

Status and phase: Suspended; Phase 3

Conditions: Carcinoma, Non-Small-Cell Lung

Treatments: Radiation: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin

Study type: Interventional

Funder types: Other

Identifiers

NCT00540280

RAC#2031-059

Details and patient eligibility

About

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

Enrollment: 10 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with early stage NSCLC

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Surgery alone

Active Comparator group

Description:

Surgery alone

Treatment:

Radiation: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin